Charles River Laboratories International, Inc. (CRL) Dividend History

Company News

• Regulatory Affairs Outsourcing Market Analysis Report 2025: Globalization of Biopharmaceutical and Medical Device Companies Bolster Growth - Trends, Opportunities, and Forecasts 2020-2030

  The global regulatory affairs outsourcing market is expected to grow significantly from 2024 to 2030, driven by the globalization of biopharmaceutical and medical device companies and the need for specialized regulatory expertise. Technological advancements in regulatory processes are also shaping the market.

  GlobeNewswire Inc.

  Featured Companies: G ICLR MEDP
• Cell-Based Assays: The Future of Biomedical Breakthroughs

  The global market for cell-based assays is expected to grow from $35.3 billion in 2024 to $56.3 billion by 2029, driven by factors such as rising incidence of chronic diseases, increasing demand for drug discovery and development, and growing investment in drug R&D.

  GlobeNewswire Inc.

  Featured Companies: A BDX BIO BIO.B DHR GEHC TMO
• High Content Screening and Imaging Market Set for 8.4% CAGR Through 2029

  The high content screening/imaging (HCS/I) market is projected to reach $5.1 billion by 2029, growing at a CAGR of 8.4%. Increasing R&D budgets and technological advances in HCS/I, such as AI integration, automation, and 3D cell models, are driving the market growth.

  GlobeNewswire Inc.

  Featured Companies: A BDX BIO BIO.B BRKR DHR GLW RVTY TMO
• The 2 Worst Performing S&P 500 Stocks YTD: Buy, Sell, or Avoid?

  The S&P 500 has faced a turbulent start to 2025, with the index down 8% year-to-date. The two worst-performing stocks, Deckers (DECK) and Charles River Laboratories (CRL), have declined 47% and 42% respectively due to tariffs and regulatory changes. Analysts remain cautiously optimistic on DECK but uncertain about CRL's long-term prospects.

  Investing.com

  Featured Companies: DECK
• Wall Street Pulls Back After Early Gains As Tariff Uncertainties Persist: What's Driving Markets Monday?

  Wall Street pared early gains as investor caution returned despite a temporary easing in U.S.-China trade tensions. Tech stocks rallied premarket but lost momentum, while defensive sectors like real estate and utilities outperformed.

  Benzinga

  Featured Companies: AMZN DVA ENPH FSLR HUM LUV PLTR SNDK SPY UNH XLRE XLY